The company depends on a limited number of suppliers for raw materials, drug substances, and drug products required for manufacturing its product candidates. Disruptions may occur if these suppliers fail to deliver adequate quantities on time or at reasonable prices. The absence of qualified backup suppliers for single-source raw materials adds to this risk. Manufacturing relationships are maintained with a small group of suppliers, some of whom require licenses to produce certain components. Any change in suppliers necessitates qualification by the FDA or other foreign regulatory authorities, which may result in delays and increased costs. Disruptions in third-party manufacturing, including challenges with scaling up production and stability testing, could delay clinical trials, regulatory approvals, and commercialization, while also increasing expenses. Additional risks include carrier disruptions, misappropriation of proprietary technology, and failure to deliver products under specified conditions.
Cocrystal Pharma Inc's Comment on Supply Chain
The company depends on a limited number of suppliers for raw materials, drug substances, and drug products required for manufacturing its product candidates. Disruptions may occur if these suppliers fail to deliver adequate quantities on time or at reasonable prices. The absence of qualified backup suppliers for single-source raw materials adds to this risk. Manufacturing relationships are maintained with a small group of suppliers, some of whom require licenses to produce certain components. Any change in suppliers necessitates qualification by the FDA or other foreign regulatory authorities, which may result in delays and increased costs. Disruptions in third-party manufacturing, including challenges with scaling up production and stability testing, could delay clinical trials, regulatory approvals, and commercialization, while also increasing expenses. Additional risks include carrier disruptions, misappropriation of proprietary technology, and failure to deliver products under specified conditions.
Sources:
Cocrystal Pharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cocrystal Pharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
